Effects of Bedtime Snack Composition on Overnight Glucose in Children and Adolescents With Type 1 Diabetes
Bedtime Snack Composition and Overnight Glycemic Profiles in Children and Adolescents With Type 1 Diabetes Using Multiple Daily Injections: A Randomized Crossover Study
1 other identifier
interventional
20
1 country
1
Brief Summary
This study compared four types of bedtime snacks in children and adolescents with type 1 diabetes treated with multiple daily insulin injections. The aim was to determine whether bedtime snack nutrient composition affects overnight glucose levels. Participants received four different bedtime snacks: carbohydrate alone, carbohydrate with protein, carbohydrate with fat, and carbohydrate with fiber. The order of the four snack types was randomly assigned. Each snack type was consumed at 9:00 PM for three consecutive nights without an additional insulin dose for the snack. All participants received all four snack types during the study. Overnight glucose levels were measured from 9:00 PM to 9:00 AM using a blinded continuous glucose monitoring system. The primary outcome was the percentage of time glucose levels remained between 70 and 180 mg/dL during the overnight period. Secondary outcomes included measures of hypoglycemia, hyperglycemia, glucose variability, and changes in glucose levels during different periods of the night.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 19, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 19, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 16, 2021
CompletedFirst Submitted
Initial submission to the registry
August 13, 2026
CompletedFirst Posted
Study publicly available on registry
August 21, 2026
CompletedAugust 21, 2026
August 1, 2026
Same day
August 13, 2026
August 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Overnight Time in Range (70-180 mg/dL)
Percentage of continuous glucose monitoring (CGM) readings within the target glucose range of 70-180 mg/dL during the overnight period following each bedtime snack intervention.
12 hours after bedtime snack consumption (21:00-09:00)
Secondary Outcomes (13)
Mean Overnight Sensor Glucose
12 hours after bedtime snack consumption (21:00-09:00)
Percentage of Overnight Time in Tight Range (70-140 mg/dL)vernight Sensor Glucose
12 hours after bedtime snack consumption (21:00-09:00)
Percentage of Overnight Time Below Range (<70 mg/dL)
12 hours after bedtime snack consumption (21:00-09:00)
Percentage of Overnight Time Below Range (<54 mg/dL)
12 hours after bedtime snack consumption (21:00-09:00)
Percentage of Overnight Time Above Range (>180 mg/dL)
12 hours after bedtime snack consumption (21:00-09:00)
- +8 more secondary outcomes
Study Arms (4)
Sequence 1: CHO First
EXPERIMENTALParticipants received the four bedtime snack interventions in the following order: CHO, CHO+PRO, CHO+FAT, and CHO+FIB.
Sequence 2: CHO+PRO First
EXPERIMENTALParticipants received the four bedtime snack interventions in the following order: CHO+PRO, CHO+FAT, CHO+FIB, and CHO.
Sequence 3: CHO+FAT First
EXPERIMENTALParticipants received the four bedtime snack interventions in the following order: CHO+FAT, CHO+FIB, CHO, and CHO+PRO.
Sequence 4: CHO+FIB First
EXPERIMENTALParticipants received the four bedtime snack interventions in the following order: CHO+FIB, CHO, CHO+PRO, and CHO+FAT.
Interventions
Participants consumed an apple as a carbohydrate-only bedtime snack at 21:00. The snack was consumed within 10 minutes, and no additional bolus insulin was administered for the snack. This intervention was followed for three consecutive nights.
Participants consumed a high-protein fresh cheese bedtime snack containing carbohydrate and protein at 21:00. The snack was consumed within 10 minutes, and no additional bolus insulin was administered for the snack. This intervention was followed for three consecutive nights.
Participants consumed an apple with nuts as a carbohydrate-plus-fat bedtime snack at 21:00. The snack was consumed within 10 minutes, and no additional bolus insulin was administered for the snack. This intervention was followed for three consecutive nights.
Participants consumed rye crispbread as a carbohydrate-plus-fiber bedtime snack at 21:00. The snack was consumed within 10 minutes, and no additional bolus insulin was administered for the snack. This intervention was followed for three consecutive nights.
Eligibility Criteria
You may qualify if:
- Age 6-18 years Diagnosis of type 1 diabetes for more than 1 year Completion of the remission period Treatment with multiple daily insulin injections Completion of all three stages of carbohydrate-counting education Ability to perform capillary blood glucose monitoring at least four times daily Total daily insulin dose \>0.5 U/kg/day Mean HbA1c \<9.6% during the preceding 3 months
You may not qualify if:
- Insulin pump or sensor-augmented pump therapy Incomplete carbohydrate-counting education Impaired awareness of hypoglycemia Intestinal malabsorption Delayed gastric emptying Celiac disease or any other condition requiring dietary restriction Cystic fibrosis or other gastrointestinal disorders Diabetes-related chronic complications Physical or mental disability limiting adherence to study procedures Eating behavior disorders Active infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Didem Güneş Kayalead
Study Sites (1)
Istanbul University Cerrahpasa-Cerrahpasa Faculty of Medicine
Istanbul, Fatih, 34098, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 13, 2026
First Posted
August 21, 2026
Study Start
November 19, 2020
Primary Completion
November 19, 2020
Study Completion
August 16, 2021
Last Updated
August 21, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will share
De-identified individual participant data underlying the results reported in the publication may be shared upon reasonable request, subject to ethical and privacy restrictions and applicable institutional requirements.